|
|
Volumn 11, Issue 3, 1997, Pages 271-279
|
|
The development of resistance of HIV-1 to zalcitabine
a
|
|
Author keywords
Antiviral therapy; Didanosine; HIV; Lamivudine; Resistance; Zalcitabine; Zidovudine
|
|
Indexed keywords
DIDANOSINE;
LAMIVUDINE;
NEVIRAPINE;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
AMINO ACID SUBSTITUTION;
ANTIVIRAL ACTIVITY;
CLINICAL TRIAL;
CROSS RESISTANCE;
DISEASE COURSE;
DRUG RESISTANCE;
DRUG STRUCTURE;
GENE MUTATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATIENT CARE;
PRIORITY JOURNAL;
REVIEW;
SITE DIRECTED MUTAGENESIS;
AMINO ACIDS;
ANTI-HIV AGENTS;
DIDANOSINE;
DRUG RESISTANCE, MICROBIAL;
HIV INFECTIONS;
HIV-1;
HIV-1 REVERSE TRANSCRIPTASE;
HUMANS;
LAMIVUDINE;
MODELS, MOLECULAR;
REVERSE TRANSCRIPTASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VARIATION (GENETICS);
ZALCITABINE;
|
|
EID: 0031029291
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-199703110-00003 Document Type: Review |
|
Times cited : (24)
|
|
References (88)
|
